In May 2025 his work published in New England Journal of Medicine described “patient-specific in vivo gene editing” to save a baby’s life born with an incurable metabolic disease, for the first time in the world which opens the door to save millions of more lives in the future curing many other genetic disorders, ushering the future era of “molecular (genetic) surgery”, a brand new clinical medical specialty.